Russell Beyer
Direttore Finanziario/CFO presso SAB Sciences, Inc.
Patrimonio netto: 1 171 $ in data 30/04/2024
Profilo
Russell P.
Beyer is currently the Chief Financial Officer at SAB Sciences, Inc. He previously held the same position at SAB Biotherapeutics, Inc. from 2021 to 2023.
Prior to that, he was the Chief Financial Officer at Big Cypress Acquisition Corp.
Mr. Beyer received an undergraduate degree from St. Lawrence University and an MBA from the University of Rochester Simon Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
14/03/2023 | 292 ( 0.00% ) | 1 171 $ | 30/04/2024 |
Posizioni attive di Russell Beyer
Società | Posizione | Inizio |
---|---|---|
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Direttore Finanziario/CFO | 01/09/2021 |
Precedenti posizioni note di Russell Beyer
Società | Posizione | Fine |
---|---|---|
SAB BIOTHERAPEUTICS, INC. | Direttore Finanziario/CFO | 27/10/2023 |
BIG CYPR | Direttore Finanziario/CFO | - |
Formazione di Russell Beyer
St. Lawrence University | Undergraduate Degree |
University of Rochester Simon Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SAB BIOTHERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
SAB Sciences, Inc.
SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million. | Health Technology |
Big Cypress Acquisition Corp.
Big Cypress Acquisition Corp. Financial ConglomeratesFinance Big Cypress Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination. The company was founded on November 12, 2020 and is headquartered in Miami Beach, FL. | Finance |
- Borsa valori
- Insiders
- Russell Beyer